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The ten-eleven-translocation 5-methylcytosine diox-
ygenase (TET) family of enzymes catalyzes the con-
version of 5-methylcytosine (5-mC) to 5-hydroxyme-
thylcytosine (5-hmC), a modified cytosine base that
facilitates gene expression. Cells respond to hypoxia
by inducing a transcriptional program regulated
in part by oxygen-dependent dioxygenases that
require Fe(II) and a-ketoglutarate. Given that the
TET enzymes also require these cofactors, we
hypothesized that the TETs regulate the hypoxia-
induced transcriptional program. Here, we demon-
strate that hypoxia increases global 5-hmC levels,
with accumulation of 5-hmC density at canonical
hypoxia response genes. A subset of 5-hmC gains
colocalize with hypoxia response elements facili-
tating DNA demethylation and HIF binding. Hypoxia
results in transcriptional activation of TET1, and full
induction of hypoxia-responsive genes and global
5-hmC increases require TET1. Finally, we show
that 5-hmC increases and TET1 upregulation in hyp-
oxia are HIF-1 dependent. These findings establish
TET1-mediated 5-hmC changes as an important
epigenetic component of the hypoxic response.INTRODUCTION
The TET proteins are dioxygenases that convert 5-methylcyto-
sine (5-mC) to 5-hydroxymethylcytosine (5-hmC) (Kriaucionis
and Heintz, 2009; Tahiliani et al., 2009). Whereas 5-mC re-
presses transcription (Jones, 2012), elevated 5-hmC levels are
associated with increased gene expression (Gan et al., 2013;
Madzo et al., 2014; Szulwach et al., 2011). Colocalization of 5-
hmC with regulatory regions such as transcription factor binding
sites, promoters, and enhancers suggests that 5-hmC hasCimportant regulatory functions (Madzo et al., 2014; Pastor
et al., 2011; Stroud et al., 2011; Williams et al., 2011; Wu et al.,
2011). 5-hmC also serves as an intermediate in demethylation
pathways (Branco et al., 2012). Three TET enzymes have been
identified: TET1, TET2, and TET3. TET1 is highly expressed in
embryonic stem cells and is upregulated in the generation of
induced pluripotent stem cells (Ito et al., 2010; Koh et al.,
2011; Piccolo et al., 2013). TET2 and TET3 are required for
normal hematopoiesis and early reprogramming of the mamma-
lian zygote, respectively (Ficz et al., 2011; Gu et al., 2011; Iqbal
et al., 2011; Madzo et al., 2013; Wossidlo et al., 2011). These
studies demonstrate that TET-mediated conversion of 5-mC to
5-hmC is an important epigenetic component of transcriptional
regulation.
Hypoxia is a pervasive stimulus that affects a wide variety of
biological processes. In tumor biology, rapid cellular proliferation
and abnormal tumor vasculature result in highly hypoxic regions
that confer an aggressive phenotype by upregulating angio-
genic, metabolic, survival, proliferative, and metastatic path-
ways (Majmundar et al., 2010). Study of the transcriptional
response to hypoxia has largely focused on the hypoxia induc-
ible factors (HIFs) HIF-1 and HIF-2, which are a-b heterodimer
transcription factors. HIFa subunits are targeted for degradation
by O2, Fe(II), and a-ketoglutarate-dependent prolyl hydro-
xylases. These hydroxylases have reduced activity in hypoxia,
resulting in HIFa accumulation (Kaelin and Ratcliffe, 2008; Prab-
hakar and Semenza, 2012).
Epigenetic regulation plays an important role in regulating
transcriptional changes in hypoxia. Genes encoding for the O2,
Fe(II), and a-ketoglutarate-dependent jumonji domain (JmJ) his-
tone demethylases are transcriptionally upregulated in hypoxia
(Beyer et al., 2008; Pollard et al., 2008; Scho¨del et al., 2011),
and global changes in many histone modifications, such as
H3K4me3, have also been reported (Johnson et al., 2008).
Site-specific changes in histone modifications have been
observed at hypoxia-induced genes including CA9, LDHA, and
PDK1 (Luo et al., 2012; van den Beucken et al., 2009). In addition,
hypoxia affects DNA methylation (Liu et al., 2011; Shahrzad
et al., 2007; Skowronski et al., 2010) and regulates noncodingell Reports 7, 1343–1352, June 12, 2014 ª2014 The Authors 1343
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Figure 1. Global 5-hmC Levels Increase in
Hypoxia
(A) Quantitation of 5-hmC by HPLC-MS/MS in
various cancer cell lines exposed to 48 hr of
hypoxia (NB, neuroblastoma; NHL, non-Hodgkin
lymphoma; DLBCL, diffuse large B cell lymphoma;
ER, estrogen receptor; PR, progesterone receptor).
Percentage 5-hmC is calculated relative to the
sum of all cytosine species (nR 3).
(B) Quantitation of 5-hmC by HPLC-MS/MS in
SK-N-BE(2) cells exposed to 24, 48, or 72 hr of
hypoxia (nR 3).
(C) Dot blot quantification of 5-hmC in SK-N-BE(2)
cells exposed to 48 hr of hypoxia.
(D) Quantification of 5-mC by HPLC-MS/MS in
SK-N-BE(2) cells. Percentage 5-mC is calculated
relative to the sum of all cytosine species (nR 3).
Data represent means ± SEM. p values calculated
by Student’s t test, *p < 0.05, **p < 0.01. See also
Figure S1.RNAs providing additional layers of epigenetic regulation
(Choudhry et al., 2014). Despite the evidence that hypoxia in-
duces epigenetic alterations, whether hypoxia also affects global
or site-specific 5-hmC levels is not known.We hypothesized that
the TETs play a role in regulating the transcriptional response to
hypoxia, because, like the JmJ histone demethylases and the
HIFa prolyl hydroxylases, the TETs require O2, Fe(II), and a-keto-
glutarate for their activity.
RESULTS
Hypoxia Increases Global 5-hmC Levels
We explored the role of TET-mediated 5-hmC changes in regu-
lating the hypoxia-induced transcriptional programbymeasuring
changes in global 5-hmC levels by high performance liquid chro-
matography coupled with tandem mass spectrometry (HPLC-
MS/MS) in a variety of cancer cells after treatment with 1% O2
for 48 hr: SK-N-BE(2), NBL-WN, La1-55n, SHEP, and SK-N-AS
(neuroblastoma); Farage (non-HodgkinBcell lymphoma), Karpas
422 (diffuse large B cell lymphoma with t[11;14]), HeLa (cervical
cancer), HN5 (head and neck cancer), MDA-MB-231 (triple-
negative breast cancer), and T47D (ER+ PR+ breast cancer).
Although many cancer cell lines had low levels of 5-hmC in
both hypoxia and normoxia, we found that 5-hmC increased after
hypoxia in tumorigenic N-type neuroblastoma cells, but not in
nontumorigenic S-type cells, despite the fact the TET enzymes
depend on oxygen (Figures 1A and S1A). We further pursued
the functional significance of 5-hmC increases in neuroblastoma
cells for several reasons. First, neuroblastomas are derived from
neural crest cells and neuronal cell types have high levels of 5-
hmC (Globisch et al., 2010; Szulwach et al., 2011). Second, neu-
roblastoma cells dedifferentiate in hypoxia (Bhaskara et al., 2012;
Jo¨gi et al., 2002, 2004), suggesting that altered differentiation
could be driven by 5-hmC changes because the TET enzymes1344 Cell Reports 7, 1343–1352, June 12, 2014 ª2014 The Authorsregulate transitions between pluripotent
and differentiated states (Ito et al., 2010;
Koh et al., 2011; Madzo et al., 2014).To further characterize the timeline of 5-hmC increases, SK-N-
BE(2) cells were exposed to 24, 48, and 72 hr of hypoxia, and
5-hmC levels were analyzed by HPLC-MS/MS. HIF-1a protein
levels were elevated in hypoxia exposed cells at all time points,
demonstrating that cells were oxygen deprived (Figure S1B).
5-hmC levels were elevated in cells exposed to 48 and 72 hr of
hypoxia (Figures 1B and S1C). Increased 5-hmC levels in hypox-
ic SK-N-BE(2) cells were also observed by dot blot assay after
labeling 5-hmC with biotin (Figure 1C) (Song et al., 2011). In
contrast to the observed changes in 5-hmC, 5-mC levels
remained unchanged at all time points (Figures 1D and S1D).
Hypoxia-induced 5-hmC gains were largely reversed following
reoxygenation (Figure S1E).
5-hmC Gains Occur at Hypoxia-Regulated Genes
To determine the genomic positions gaining 5-hmC in hypoxia,
we purified and sequenced 5-hmC-enriched DNA fragments
from SK-N-BE(2) cells exposed to 48 hr of hypoxia using the
hMe-Seal method (Song et al., 2011) in two independent bio-
logical replicates (Figures S2A and S2B). RNA sequencing
(RNA-seq) was performed to quantify transcriptional changes.
To determine the distribution of 5-hmC gains across the
genome, we summed gained hMe-Seal sequencing tags over
various genomic elements (exons, introns, untranslated regions
[UTRs], CpG islands/shores, and intergenic regions). To test
for potential regulatory function of 5-hmC, the positions of pre-
viously published HIF binding sites (Scho¨del et al., 2011), and
the locations of DNase-hypersensitive sites (DHSs) (Bernstein
et al., 2012) were included. In absolute terms, 5-hmC gains
occurred to the greatest extent over introns (Figure 2A). Enrich-
ment of 5-hmC gains at each element was then calculated by
normalizing for element length. 5-hmC gains were enriched at
or near known HIF-1 binding sites, at DHSs, and at CpG shores
(Figures 2B, S2C, and S2D). Enrichment of 5-hmC gains was
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Figure 2. 5-hmC Gains Occur at Hypoxia Regulated Regions in SK-N-BE(2) Cells
(A and B) Absolute 5-hmC gains (A) and enrichment for 5-hmC gains (B) were calculated at genomic elements. Regions flanking HIF binding sites are regions ±1
kb from the ChIP-seq peak. Footprints include the ChIP-seq peak and flanking region (Scho¨del et al., 2011). Data represent means ± SD for two biological
replicates.
(C) PANTHER pathway analysis of genes with regions gaining at least 3-fold 5-hmC. p values are Bonferroni corrected results of binomial tests (Mi et al., 2013).
(D) Regions gaining the most 5-hmC map to the HIF-1 target genes CA9, PGK1, GPI, VEGFA, BNIP3, and ENO1. Plotted points represent combined data from
two experiments.
(legend continued on next page)
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greater at or near unique HIF-1 binding sites (sites that bind HIF-
1, but not HIF-2) than at unique HIF-2 binding sites (sites that
bind HIF-2, but not HIF-1) (Scho¨del et al., 2011).
We performed PANTHER pathway analysis on the genes with
a 3-fold increase of 5-hmC density in hypoxia and identified
pathways such as dopamine receptor mediated signaling,
glycolysis, angiogenesis, and hypoxia response via HIF activa-
tion (Figure 2C). For each genomic position, we plotted the
number of sequencing tags mapping to the region for the control
and hypoxia samples. This analysis demonstrated that regions
gaining the most 5-hmC map to canonical hypoxia response
genes, including CA9, PGK1, GPI, VEGFA, BNIP3, and ENO1
(Figure 2D). 5-hmC gains occurred over gene bodies and/or
promoter regions of these genes (Figures 2E–2H and S2E–
S2H). To resolve 5-hmC, 5-mC, and unmodified cytosine at
single-base resolution at loci that gain 5-hmC in hypoxia,
we performed Tet-assisted bisulfite sequencing (TAB-seq) (Yu
et al., 2012) at the PGK1 first intron, and the BNIP3 promoter
and first intron (Figures 2I and 2J). Given previous reports that
5-hmC is associated with transcription factor binding sites
(Gan et al., 2013; Madzo et al., 2014), we used Homer motif anal-
ysis to calculate enrichment for putative transcription factor
binding sites at positions gaining 5-hmC in hypoxia. We identi-
fied these regions as enriched for binding sites of ZFX, Eomes,
ZNF711, NeuroD1, N-Myc, Foxo1, Max, c-Myc, Stat3, and the
androgen receptor (Table S1). Finally, we repeated hMe-Seal
and RNA-seq experiments in a second neuroblastoma cell line,
NBL-WN. NBL-WN cells gained 5-hmC at similar genomic anno-
tations and hypoxia-responsive genes (Figures S2I–S2L). These
results implicate 5-hmC as an important regulator of the hypox-
ia-induced transcriptional program.
TET1 Expression Increases in Hypoxia and Is Necessary
for Hypoxic Gene Induction
Given the dependence of TET enzymes on oxygen, we were sur-
prised to find global increases of 5-hmC in hypoxia. Therefore,
we hypothesized that transcriptional increases in one or more
TET genes could compensate for potentially lower enzymatic
activity in hypoxia, as has been shown for the HIFa prolyl hydro-
xylases (Stiehl et al., 2006). We found that TET1 transcription
increased in SK-N-BE(2) cells in hypoxia as measured by quan-
titative PCR (qPCR) (Figure 3A), whereas no changes in TET2 or
TET3 mRNA levels were observed (Figure 3B). These TET
expression results were also observed by RNA-seq (Figure 3C).
Like 5-hmC levels, the increase in TET1 mRNA was reversed
after reoxygenation (Figure S3A) and was observed in other
N-type, but not S-type, cell lines (Figure 3D). To determine
whether the TETs are induced in hypoxia in other cancer cell
lines, we quantified TET1, TET2, and TET3 expression after
48 hr of hypoxia in Farage, Karpas 422, HeLa, HN5, MDA-MB-
231, and T47D cells. We only observed induction of TET2 by
hypoxia in Karpas 422 cells (Figures S3B–S3D).(E–H) RNA-seq and hMe-Seal sequencing data are plotted in the Integrated Geno
RefSeq gene tracks represent the position of known genes in the hg19 build of t
(I and J) TAB-seq data for the corresponding shaded regions of PGK1 (G) andBNIP
5-hmC, and unmodified cytosine, respectively. Results represent pooled data o
See also Figure S2 and Table S2.
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TET1 was responsible for global 5-hmC gains. We tested this
by knocking down TET1 with small interfering RNA (siRNA) and
noted that this treatment did not interfere with HIF-1a accumu-
lation (Figure 3E). We found that TET1 depletion inhibited global
5-hmC gains (Figure 3F). We then tested if TET1 activity is neces-
sary for full induction of genes gaining 5-hmC in hypoxia using
cells transiently depleted of TET1 with siRNA or cells stably
expressing a TET1-targeting short hairpin RNA (shTET1) (Fig-
ure S3E). In addition to genes identified as gaining large amounts
of 5-hmC in Figure 2, we included HK2 in our analysis, because
it gained narrow 5-hmC peaks over its promoter and first intron
in our hMe-Seal experiments (Figure S3F). TET1 depletion blunt-
ed hypoxia-induced induction of CA9, BNIP3, and VEGFA at
16 hr of hypoxia (Figures S3G and S3H). After 48 hr of hypoxia,
TET1 depletion attenuated PGK1 and HK2 expression, in addi-
tion to CA9, BNIP3, and VEGFA (Figures 3G and 3H). These
experiments show that TET1 is required for full induction of the
hypoxic transcriptional program.
Interestingly,CA9 expression is delayed in hypoxic neuroblas-
toma cells relative to other hypoxia-induced genes (Figures S3I
and S3J) and closely mirrors the time course of global 5-hmC
gains in hypoxia (Figures 1B and S1C), suggesting that CA9
expression could be particularly dependent on epigenetic re-
modeling. Therefore, we further investigated the role of 5-hmC
gains in inducing CA9 expression. CA9 gains 5-hmC over its
transcriptional start site (TSS) where there is a well-characterized
hypoxia response element (HRE) (Wykoff et al., 2000). Because
HIF-1 binding to HREs is methylation sensitive (Wenger et al.,
1998), we tested the effect of hydroxymethylation on HIF-1 bind-
ing within the HRE using an electrophoretic mobility shift assay
(EMSA). Like 5-mC, we found that 5-hmC inhibited HIF-1 binding
(Figure 3I). We therefore hypothesized that 5-hmC may accu-
mulate near the HRE to facilitate an open chromatin state, and
that 5-hmC within the HRE would be a transient intermediate
facilitating demethylation and HIF binding. To test this hypothe-
sis, we performed TAB-seq (Yu et al., 2012) at the CA9 TSS.
Consistent with our hypothesis and the observed slow induction
kinetics of CA9, we observed small but insignificant accumula-
tion of 5-hmC at the CA9 TSS by 16 hr of hypoxia, accompanied
by an increase of unmodified cytosine at the HRE (Figure S3K).
By 48 hr of hypoxia, significant accumulation of 5-hmC at a
CpG 74 bp upstream of the TSS was observed and further
demethylation of multiple CpGs in this region, including at the
HRE, was observed (Figure 3J). To determine if 5-hmC gains at
HIF-1 chromatin immunoprecipitation sequencing (ChIP-seq)
peaks are associated with HRE demethylation at other sites,
we performed TAB-seq at two additional HIF-1 ChIP-seq peaks
associated with 5-hmC gains in hypoxia (Figures S2C and S2D).
Similar to our findings at CA9, we found that these hMe-Seal
peaks mark HREs that gained unmodified cytosine over 48 hr
of hypoxia (Figures S3L and S3M).mics Viewer (IGV) genome browser at VEGFA, CA9, PGK1, and BNIP3 genes.
he human genome. Arrows represent the direction of transcription.
3 (H). For each CpG, black, green, and gold represent the percentage of 5-mC,
ver three independent experiments. p values calculated by chi-square tests.
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Figure 3. TET1 Is Required for Full Hypoxic Gene Induction
(A) TET1 mRNA quantified by qPCR from SK-N-BE(2) cells (nR 4).
(B) TET2 and TET3 mRNA quantified by qPCR from SK-N-BE(2) cells exposed to 48 hr of hypoxia (n = 3).
(C) TET mRNA levels measured in fragments per kilobase of transcript per million mapped reads (FPKM) by RNA-seq. Data represent Cuffdiff output from two
biological replicates of SK-N-BE(2) cells exposed to 48 hr of hypoxia. p values were false discovery rate corrected.
(D) TET1 mRNA measured by qPCR in neuroblastoma cell lines exposed to 48 hr of hypoxia (nR 4).
(E) TET1 mRNA determined by qPCR, and HIF-1a expression determined by immunoblot, in SK-N-BE(2) cells transfected with siCtrl or siTET1 (n = 3).
(F) 5-hmCquantifiedbydotblot inSK-N-BE(2) cells transfectedwith siCtrl or siTET1andexposed to48hr of hypoxia.Quantification representsmeans±SEM(n=3).
(G and H) qPCR quantification of hypoxia-induced gene expression in TET1 depleted SK-N-BE(2) cells after 48 hr of hypoxia (n = 3).
(I) EMSA binding studies of HIF-1 to the CA9 HRE. c, cytosine; h, 5-hmC; m, 5-mC.
(J) TAB-seq of the CA9 TSS. The boxed CpG 6 bp upstream of the TSS resides within the HRE. Results are pooled over three replicates. p values calculated by
chi-square tests.
All graphs represent means ± SEM. p values for expression analysis calculated by Student’s t test, *p < 0.05, **p < 0.01. See also Figure S3.TET1 and Global 5-hmC Increases Are HIF-1 Dependent
We then determined the mechanisms underlying TET1 induction
and 5-hmC increases in hypoxia. We hypothesized that these
changes may be HIF-1 regulated, because (1) pathways andCgenes identified in our hMe-Seal analysis showed a strong
HIF-1 signature (Figure 2); and (2) SK-N-BE(2) and NBL-WN cells
selectively expressed HIF-1a over HIF-2a (Figure S4A), consis-
tent with a previous report (Qing et al., 2010). We generatedell Reports 7, 1343–1352, June 12, 2014 ª2014 The Authors 1347
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Figure 4. HIF-1 Regulates TET1 and Is Necessary for Genome-wide and Locus-Specific 5-hmC Gains in SK-N-BE(2) Cells
(A) qPCR quantification of HIF-1 target gene expression in shHIF-1a or shCtrl-transduced cells after 48 hr of hypoxia (n = 3).
(B and C) TET1mRNA quantification by qPCR (B) and 5-hmC quantification by HPLC-MS/MS (C) in shCtrl or shHIF-1a-transduced SK-N-BE(2) cells exposed to
48 hr of hypoxia (n = 3).
(D) Regions gaining 5-hmC from Figure 2D are plotted in shCtrl or shHIF-1a-expressing cells. Gains of 5-hmC in hypoxia are represented as an upward shift on the
y axis.
(E) PANTHER pathway analysis of regions losing 5-hmC in hypoxic shHIF-1a cells relative to hypoxic shCtrl cells. p values are Bonferroni corrected results of
binomial tests (Mi et al., 2013).
(legend continued on next page)
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SK-N-BE(2) cells expressing a previously validated short hairpin
RNA targeting either HIF-1a (shHIF-1a) (Stiehl et al., 2012) or a
nontargeting control (shCtrl). shHIF-1a efficiently reduced HIF-
1a protein levels in hypoxia and inhibited transcriptional upregu-
lation of HIF-1 target genes (Figure 4A). HIF-1a knockdown also
prevented the upregulation of TET1 and global 5-hmC increases
in hypoxia (Figures 4B, 4C, and S4B). These results demonstrate
that HIF-1 is required for hypoxic induction of TET1 and global
increases in 5-hmC.
To investigate whether site-specific 5-hmC gains are HIF-1
regulated, we repeated hMe-Seal with cells expressing shCtrl
and shHIF-1a. We analyzed genomic positions identified as
gaining 5-hmC in our initial hMe-Seal experiment and found
that shCtrl-transduced cells gained 5-hmC at these positions,
but shHIF-1a-transduced cells did not (Figure 4D). PANTHER
pathway analysis of genes losing 5-hmC in hypoxic shHIF-1a
cells relative to hypoxic shCtrl cells demonstrated that 5-hmC
depletion in hypoxic shHIF-1a cells is specific to genes regulated
byHIF-1 (Figure 4E).CA9, BNIP3, VEGFA,PGK1,GPI, andENO1
gained large amounts of 5-hmC in shCtrl-transduced cells but
showed little to no 5-hmC gains in shHIF-1a-transduced cells
(Figures 4F, 4G, and S4C–S4F). In contrast, HIF-1a knockdown
had no effect on 5-hmC levels at genes that are not regulated
by hypoxia (Figures S4G and S4H). These findings indicate that
induction of TET1 and gain of 5-hmC-density at hypoxia-induced
genes are HIF-1 dependent.
DISCUSSION
Our results demonstrate a hitherto uncharacterized role for the
TET1 dioxygenase and 5-hmC in regulating the hypoxia-induced
transcriptional program in neuroblastoma cells. We propose a
model (Figure 4H) in which TET1 is upregulated in hypoxia by
HIF-1. This is associated with TET1 and HIF-1-dependent 5-
hmC gains clustered at hypoxia-induced genes. At these genes,
TET1 facilitates expression. We find 5-hmC gains in hypoxia at
promoters, exons, introns, UTRs, and other regulatory regions,
where 5-hmC may have distinct functions. These findings raise
numerous questions that will be the subject of future work,
including the following: determining whether TET1 is a direct or
indirect transcriptional target of HIF-1; how TET1 is directed to
specific genes induced in hypoxia; and the function of 5-hmC
at different genomic elements.
We observe induction of TET1 and increase in 5-hmC within
tumorigenic, N-type neuroblastoma cells. The low levels of 5-
hmC in other cancer cells are consistent with previous reports
that (1) 5-hmC levels are reduced in numerous cancers (Mariani
et al., 2013) and (2) neuronal cells have high levels of 5-hmC
(Globisch et al., 2010; Szulwach et al., 2011). It will be important
for us and others to test an even wider range of cancer and other
cell types in the future to understand if our observations are
broadly applicable.(F and G) hMe-Seal data for parental and transduced SK-N-BE(2) cells exposed
(H) Hypoxia stimulates HIF-1-dependent upregulation of TET1, which is necessary
hypoxia response genes that require TET1 for induction.
All graphs represent means ± SEM. See also Figure S4.
COur work is consistent with previous observations that hyp-
oxia induces global and site-specific epigenetic changes (Beyer
et al., 2008; Johnson et al., 2008; Liu et al., 2011; Pollard et al.,
2008; Shahrzad et al., 2007; Skowronski et al., 2010). Our
finding that TET1 is transcriptionally upregulated in hypoxia
and subsequently facilitates hypoxia-induced gene expression
is analogous to previous findings regarding the JmJ histone
demethylases: genes encoding for JmJ histone demethylases
are HIF targets (Beyer et al., 2008; Pollard et al., 2008; Scho¨del
et al., 2011), and the protein products of these genes facilitate
hypoxic gene induction by remodeling chromatin at other HIF
targets (Luo et al., 2012). Previous work has also demonstrated
that treatment of cells with 5-azacytidine augments induction
of the hypoxia transcriptional program, particularly by demethy-
lation of HREs (Koslowski et al., 2011). This is consistent
with our observation that HIF-1 binding sites gaining 5-hmC
in our hMe-Seal experiments exhibit an increase in the amount
of unmodified cytosine at the HRE in TAB-seq experiments,
which facilitates gene induction. The fact that very little 5-
hmC accumulates at the CpG within these HREs suggests
that demethylation at these CpGs occurs quickly. Our results
further highlight the importance of chromatin remodeling in
the hypoxic response and identify 5-hmC changes as a previ-
ously unknown component of this process.
Two recent studies have demonstrated that most HIF-target
genes have promoter-proximally paused RNA PolII in normoxia,
and that HIF binding to these genes releases PolII from the
paused state (Choudhry et al., 2014; Galbraith et al., 2013).
Nonetheless, a small subset of hypoxia regulated genes recruit
PolII de novo on hypoxic exposure (Choudhry et al., 2014). Broad
5-hmC gains across the bodies of genes, such as BNIP3, sug-
gest a potential role for 5-hmC in PolII elongation, whereas
narrow 5-hmC peaks gained at or near the TSS of genes like
CA9 may facilitate PolII recruitment. Determining if 5-hmC
serves to regulate either de novo PolII recruitment or release
from the promoter-proximal paused statemay further ourmolec-
ular understanding of how hypoxia-induced genes are regulated.
Finally, our work emphasizes the importance of employing
techniques that can distinguish 5-mC from 5-hmC. A previous
study examined the effect of hypoxia on covalent cytosine mod-
ifications using Illumina 450K methylation arrays (Yuen et al.,
2013). These arrays use sodium bisulfite treatment of DNA
to distinguish modified and unmodified cytosines but cannot
distinguish between 5-mC and 5-hmC (Mariani et al., 2013).
Using these arrays, cytosine modification levels in 147 CpGs
were found to differ between cytotrophoblastic cells treated
with 24 hr of normoxia or hypoxia (Yuen et al., 2013). Only
one of the CpGs identified in this study correlates with a
location gaining 5-hmC in our data (Illumina cg 23097499,
Chr20: 62330618, associated with TNFRSF6B) (Yuen et al.,
2013). This is most likely because this previous study would be
blind to any transitions between 5-mC and 5-hmC due to theto 48 hr of hypoxia or normoxia.
for genome-wide 5-hmC increases. Site-specific 5-hmC gains are clustered at
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limitations of sodium bisulfite based techniques. Combined with
recent work that used techniques specific for 5-hmC to examine
lineage commitment of hematopoietic stem cells (Madzo et al.,
2014), our work suggests that 5-hmC may play a broad role in
regulating cellular responses that require dynamic and wide-
spread transcriptional changes. Future work should continue
to test this hypothesis using techniques specific for 5-hmC.
EXPERIMENTAL PROCEDURES
Detailed procedures are provided in the Supplemental Experimental
Procedures.
Hypoxia Exposures
Hypoxic cells were incubated under 1%O2 and 10%CO2 inmodular incubator
chambers (Billups-Rothenberg). Normoxic cells were incubated at 10% CO2
and 20% O2.
Detection of 5-hmC and 5-mC by HPLC-MS/MS
Genomic DNA was hydrolyzed to nucleosides and run on a Zorbax XDB-C18
2.1 3 50 mm column (1.8 mm particle size) attached to an Agilent 1200 Series
liquid chromatography machine coupled to an Agilent 6410 Triple Quad Mass
Spectrometer (Madzo et al., 2014; Vasanthakumar et al., 2013).
5-hydroxymethylcytosine Selective Chemical Labeling
5-hydroxymethylcytosine selective chemical labeling (hMe-Seal) was per-
formed as previously described (Song et al., 2011). Briefly, 20 mg of sonicated
genomic DNA was labeled with UDP-6-N3-glucose and biotinylated using
DMCO-S-S-PEG3-Biotin Conjugate (Click Chemistry Tools). Biotinylated
DNA was affinity purified and sequenced.
Sequence Mapping and Analysis
DNA reads were mapped to hg19 with the Burrows-Wheeler Aligner. The
BWA-mem algorithm was used for 100 bp reads and BWA-backtrack for
50 bp reads. Peak calling was performed using MACS1.4. RNA reads were
aligned using TopHat. Cufflinks and Cuffdiff were used for expression analysis.
Enrichment Calculations for 5-hmC Gains at Genomic Elements
Regions gaining 5-hmC in hypoxia were intersected with the genomic element
being analyzed. Intersections were weighted by the length of the intersection
and the amount of 5-hmCbeing gained over the intersection and then summed
genome-wide to calculate an observed value of 5-hmC gained at each
element. Expected values were calculated by scrambling 5-hmC gains over
the genome and performing the same calculation. Mean values from 1,000
scrambling experiments were used as the expected value in enrichment
calculations.
Generation of Lentivirally Transduced Cells
Production of lentivirus and subsequent infection of neuroblastoma cells fol-
lowed the protocol found at http://www.addgene.org/tools/protocols/plko/.
pLKO.1 plasmids coding for HIF-1a and TET1 targeting hairpins were previ-
ously described (Stiehl et al., 2012; Sun et al., 2013).
Transfection with TET1 siRNA
TET1 targeting siRNA (Thermo ON-TARGETplus SMARTpool D-014635) and
nontargeting control siRNA (Thermo ON-TARGETplus Non-targeting pool
L-001810) were transfected into neuroblastoma cells using Mirus TransIT-
siQUEST reagent (MIR 2114).
HIF-1 EMSA Assay
HIF-1a and ARNT were produced by IVTT using the TNT T7 Coupled Coupled
Reticulocyte Lysate System (Promega). Nucleotide probes were designed
based off of the previously characterized CA9 HIF1 binding site (Wykoff
et al., 2000): 50-CCAATGCACGTACAGCCC-30 and 50-GGGCTGTACGTGCA1350 Cell Reports 7, 1343–1352, June 12, 2014 ª2014 The AuthorsTTGG-30 with the underlined cytosine being unmodified, methylated, or
hydroxymethylated.
TAB-seq
TAB-seq was performed using the Wisegene 5-hmC Tab-seq kit. Ten micro-
grams of DNA was sonicated to 500 bp and conjugated to UDP-glucose
with b-glycosyltransferase. After reaction cleanup, conjugated DNA was
oxidized using mTet1, and bisulfite treated. Glycosylated DNA without
mTet1 oxidation was used for quantification of modified and unmodified
cytosines. After PCR amplification, products were TOPO TA cloned (Life Tech-
nologies K4575-02) and sequenced.
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Next generation sequencing data sets are available at http://www.ncbi.
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